Large-scale testing (Phase 3)Study completedNCT02435173What this trial is testingStudy of Efficacy of CDZ173 in Patients With APDS/PASLIWho this might be right forCommon Variable Immunodeficiency (CVID), APDS / PASLI Novartis Pharmaceuticals 37